Nova Pharma Solutions Bhd (XKLS:03006) EV-to-EBIT : 5.28 (As of May. 26, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nova Pharma Solutions Bhd's Enterprise Value is RM25.97 Mil. Nova Pharma Solutions Bhd's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was RM4.92 Mil. Therefore, Nova Pharma Solutions Bhd's EV-to-EBIT for today is 5.28.

The historical rank and industry rank for Nova Pharma Solutions Bhd's EV-to-EBIT or its related term are showing as below:

XKLS:03006' s EV-to-EBIT Range Over the Past 10 Years
Min: -50.47 Med: 18.31 Max: 48.4
Current: 5.28

During the past 9 years, the highest EV-to-EBIT of Nova Pharma Solutions Bhd was 48.40. The lowest was -50.47. And the median was 18.31.

XKLS:03006's EV-to-EBIT is not ranked
in the Construction industry.
Industry Median: 11.34 vs XKLS:03006: 5.28

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nova Pharma Solutions Bhd's Enterprise Value for the quarter that ended in Dec. 2023 was RM20.85 Mil. Nova Pharma Solutions Bhd's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was RM4.92 Mil. Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 23.58%.

Nova Pharma Solutions Bhd EV-to-EBIT Historical Data

The historical data trend for Nova Pharma Solutions Bhd's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Pharma Solutions Bhd EV-to-EBIT Chart

Nova Pharma Solutions Bhd Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

38.91

-46.26

48.40

18.31

4.24

Nova Pharma Solutions Bhd Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial											48.40	-	18.31	-	4.24

Competitive Comparison of Nova Pharma Solutions Bhd's EV-to-EBIT

For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Pharma Solutions Bhd's EV-to-EBIT Distribution in the Construction Industry

For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nova Pharma Solutions Bhd's EV-to-EBIT falls into.

Nova Pharma Solutions Bhd EV-to-EBIT Calculation

Nova Pharma Solutions Bhd's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	25.965	/	4.916
	=	5.28

Nova Pharma Solutions Bhd's current Enterprise Value is RM25.97 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Pharma Solutions Bhd's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was RM4.92 Mil.

Nova Pharma Solutions Bhd (XKLS:03006) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nova Pharma Solutions Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	4.916	/	20.8503
	=	23.58 %

Nova Pharma Solutions Bhd's Enterprise Value for the quarter that ended in Dec. 2023 was RM20.85 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Pharma Solutions Bhd's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was RM4.92 Mil.

Nova Pharma Solutions Bhd EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » EV-to-EBIT

Traded in Other Exchanges

N/A

Address

Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650

Website

http://www.novapharmasolutions.com

Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines